RAMMURTI KAMBLE to Neoplasms, Second Primary
This is a "connection" page, showing publications RAMMURTI KAMBLE has written about Neoplasms, Second Primary.
Connection Strength
0.680
-
Risk Factors for Subsequent Central Nervous System Tumors in Pediatric Allogeneic Hematopoietic Cell Transplant: A Study from the Center for International Blood and Marrow Transplant Research (CIBMTR). Biol Blood Marrow Transplant. 2017 Aug; 23(8):1320-1326.
Score: 0.121
-
Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcome. Bone Marrow Transplant. 2015 Aug; 50(8):1057-62.
Score: 0.106
-
Secondary solid cancer screening following hematopoietic cell transplantation. Bone Marrow Transplant. 2015 Aug; 50(8):1013-23.
Score: 0.105
-
New cancers after autotransplantations for multiple myeloma. Biol Blood Marrow Transplant. 2015 Apr; 21(4):738-45.
Score: 0.103
-
Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioning. Biol Blood Marrow Transplant. 2014 Nov; 20(11):1777-84.
Score: 0.100
-
Second malignancies after autologous hematopoietic cell transplantation in children. Bone Marrow Transplant. 2013 Mar; 48(3):363-8.
Score: 0.088
-
Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma. Biol Blood Marrow Transplant. 2017 Feb; 23(2):269-277.
Score: 0.029
-
A prognostic model predicting autologous transplantation outcomes in children, adolescents and young adults with Hodgkin lymphoma. Bone Marrow Transplant. 2015 Nov; 50(11):1416-23.
Score: 0.027